Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in d-galactosamine-treated rats
- 2019-11-12
- Clinical Trial
- Applied Microbiology and Biotechnology 103(23-24)
- Qiangqiang Wang
- L. Lv
- Huiyong Jiang
- Kaicen Wang
- Ren Yan
- Yating Li
- Jianzhong Ye
- Jingjing Wu
- Qing Wang
- Xiaoyuan Bian
- Liya Yang
- Xianwan Jiang
- Jiaojiao Xie
- Yanmeng Lu
- Jian Shen
- Lanjuan Li
- PubMed: 31713675
- DOI: 10.1007/s00253-019-10211-8
- Low evidence
- Animal Study
L. helveticus R0052 ameliorated intestinal abnormalities and regulated Toll-like receptors, claudin2 and mucin3 gene transcription in the intestine.
- Effect
- Beneficial
- Effect size
- Moderate